Company Analysis - Teva Pharmaceutical Industries Ltd.
RNCOS
January 1, 2012 35 Pages - SKU: CICQ6750145
|
|
Company Analysis assists individual investors, managers and companies in evaluating opportunities, trends, market innovations as well as in selecting appropriate information solutions in order to make effective investment decisions.
The study covers information on the business structure, areas of operation, products and services offered by the company. It comprises SWOT analysis, Key Ratios, and financials that aid investors in gaining an insight into the company's performance.
The report is an outcome of extensive research and makes use of data provided by various credible publications, trade journals, industry associations, and the company sources.
Report Highlights
- Provides a comprehensive version of the company's performance
- Offers key financial data, ratio and SWOT analysis
- Tracks major M&A trends and developments
- Business Profile, SWOT analysis and financial information on top competitors
- View on the company by our analysts
- Supplemented with graphs and tabular information wherever necessary
|
- 1. Company Overview
- 1.1 History
- 1.2 Business Overview
- 1.3 Organizational Structure
- 1.4 Major Mergers & Acquisitions
- 1.5 Ticker Codes at Various Stock Exchange Listings
- 1.6 Management Profile
- 2. Product & Services
- 2.1 Product & Services - An Overview
- 2.2 Revenue Summary by Product Division
- 2.3 Revenue Summary by Geographical Distribution
- 3. Financial Information for the Fiscal Year
- 3.1 Financial Summary for the Fiscal Year
- 3.2 Breakup of Revenue & Sales Trends
- 3.3 Ratio & Market Indicators
- 3.4 Earnings & Income Estimates
- 3.5 Stock Analysis
- 4. SWOT Analysis
- 4.1 Strengths
- 4.2 Weaknesses
- 4.3 Opportunity
- 4.4 Threats
- 5. Top Competitors (Key Financials & SWOT Analysis)
- 5.1 Watson Pharmaceuticals, Inc.
- 5.2 Forest Laboratories, Inc.
- 5.3 Novartis AG
- 5.4 Pfizer Inc.
- 6. Analyst View
- List of Figures:
- Figure 2-1: Teva Pharmaceutical Industries Ltd. - Revenue by Product Division (Million US$), 2009 & 2010
- Figure 2-2: Teva Pharmaceutical Industries Ltd. - Revenue by Geographical Distribution (Million US$), 2009 & 2010
- Figure 3-1: Teva Pharmaceutical Industries Ltd. - Stock Chart
- List of Tables:
- Table 1-1: Teva Pharmaceutical Industries Ltd. - Major Mergers & Acquisitions (2008-2011)
- Table 1-2: Teva Pharmaceutical Industries Ltd. - Ticker Codes at various Stock Exchange
- Table 1-3: Teva Pharmaceutical Industries Ltd. - Key Management People
- Table 3-1: Teva Pharmaceutical Industries Ltd. - Financial Overview (Million US$), 2010
- Table 3-2: Teva Pharmaceutical Industries Ltd. - Breakup of Revenue & Sales (Million US$), 2008-2010
- Table 3-3: Teva Pharmaceutical Industries Ltd. - Key Financial Ratios (2008-2010)
- Table 3-4: Teva Pharmaceutical Industries Ltd. - Earnings & Income Estimates (Million US$), 2008-2010
- Table 5-1: Watson Pharmaceuticals, Inc. - Key Financials (Million US$), 2008-2010
- Table 5-2: Watson Pharmaceuticals, Inc. - SWOT Analysis
- Table 5-3: Forest Laboratories, Inc. - Key Financials (Million US$), FY 2009 to FY 2011
- Table 5-4: Forest Laboratories, Inc. - SWOT Analysis
- Table 5-5: Novartis AG - Key Financials (Million US$), 2008-2010
- Table 5-6: Novartis AG - SWOT Analysis
- Table 5-7: Pfizer Inc. - Key Financials (Million US$), 2008-2010
- Table 5-8: Pfizer Inc. - SWOT Analysis
Share this report
Other tasks Related Markets Pharmaceuticals Company Reports Free Alert Me service Receive bi-weekly email alerts on new market research Sign Up Today!
|
